HACCP
This article was originally published in The Tan Sheet
Executive Summary
Development of Hazard Analysis and Critical Control Points for dietary supplement companies urged by clients of D.C.-based law firm Emord & Associates, who say FDA's proposed GMP standards for supplements would economically harm small businesses by substantially raising production costs without increasing safety and quality. The plaintiffs in the Pearson v. Shalala case say the agency lacks a sufficient scientific basis upon which to ground GMPs for the entire industry and supplement companies are in the best position to identify their own production risks and appropriate countermeasures
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning